WallStreetZenWallStreetZen

NASDAQ: KALV
Kalvista Pharmaceuticals Inc Stock Ownership - Who owns Kalvista Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Kalvista Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Thomas Andrew CrockettCEO2024-02-2024,888$14.12
$351.29kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2024-02-2012,053$14.12
$170.13kSell
Paul K. AudhyaCHIEF MEDICAL OFFICER2024-02-2014,295$14.12
$201.77kSell
Benjamin L. PalleikoCFO CBO2024-02-2022,802$14.12
$321.85kSell
Edward P. FeenerCHIEF SCIENTIFIC OFFICER2024-02-208,397$14.12
$118.52kSell
Edward P. FeenerCHIEF SCIENTIFIC OFFICER2024-02-2019,591$14.04
$275.00kSell
Edward P. FeenerCHIEF SCIENTIFIC OFFICER2024-02-20300$14.72
$4.42kSell
Benjamin L. PalleikoCFO CBO2024-02-1440,855$15.01
$613.19kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2024-02-1439,886$15.01
$598.65kSell
Thomas Andrew CrockettCEO2024-02-1458,356$15.01
$875.87kSell

1 of 6

KALV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KALV insiders and whales buy or sell their stock.

KALV Shareholders

What type of owners hold Kalvista Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Ventures Vi LLC19.93%8,409,126$97.29MInsider
Venrock Healthcare Capital Partners Iii LP11.44%4,824,731$55.82MInsider
Interwest Management Partners Ix LLC10.95%4,619,196$53.44MInsider
Guy P. Nohra10.30%4,343,550$50.25MInsider
Acmp Iv LLC10.30%4,343,550$50.25MInsider
Vr Adviser LLC9.70%4,092,731$47.35MInstitution
Frazier Life Sciences Management LP8.59%3,622,294$41.91MInstitution
Tang Capital Management LLC8.15%3,440,345$39.80MInstitution
Tcg Crossover Management LLC8.05%3,395,495$39.29MInstitution
Albert Cha7.00%2,951,631$34.15MInsider

1 of 3

KALV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KALV48.19%51.81%Net BuyingNet Buying
AVBP0.00%34.25%Net BuyingNet Buying
URGN62.74%29.32%Net BuyingNet Selling
FATE61.86%38.14%Net SellingNet Selling
THRD73.29%26.71%Net BuyingNet Buying
View Top Biotech Stocks

Kalvista Pharmaceuticals Stock Ownership FAQ

Who owns Kalvista Pharmaceuticals?

Kalvista Pharmaceuticals (NASDAQ: KALV) is owned by 87.66% institutional shareholders, 94.23% Kalvista Pharmaceuticals insiders, and 0.00% retail investors. Vivo Ventures Vi LLC is the largest individual Kalvista Pharmaceuticals shareholder, owning 8.41M shares representing 19.93% of the company. Vivo Ventures Vi LLC's Kalvista Pharmaceuticals shares are currently valued at $96.20M.

If you're new to stock investing, here's how to buy Kalvista Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.